Search

Displaying results 9531 - 9540 of 10000 in total
  1. Drug

    Licaminlimab

    go.drugbank.com/drugs/DB18936
    Investigational

    Licaminlimab is under investigation in clinical trial NCT05896670 (Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Dry Eye Disease).

  2. Drug

    Lilotomab

    go.drugbank.com/drugs/DB19076
    Investigational

    Lilotomab is under investigation in clinical trial NCT01796171 (A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-hodgkin Lymphoma).

  3. Drug

    Alphacetylmethadol

    go.drugbank.com/drugs/DB01555
    ExperimentalIllicit

    It is used mainly in the treatment of narcotic dependence. [PubChem]

  4. Drug

    Oxymatrine

    go.drugbank.com/drugs/DB16276
    Investigational

    Oxymatrine is under investigation in clinical trial NCT02202473 (Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects).

  5. Drug

    Aklavine

    go.drugbank.com/drugs/DB19070
    Experimental

    Aklavine is under investigation in clinical trial NCT03026842 (Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With T(8;21)).

  6. Drug

    Nicotinyl alcohol

    go.drugbank.com/drugs/DB04145
    Experimental

    It is used in vasospasm and threatened gangrene. [PubChem]

  7. Drug

    TAK-751S

    go.drugbank.com/drugs/DB06432
    Investigational

    TAK-751S is a synthetic analog of Shiga toxin (Stx) receptor, Gb3, produced by enterohemorrhagic Escherichia coli.

  8. Drug

    Minodronic acid

    go.drugbank.com/drugs/DB06548
    Investigational

  9. Drug

    Atiprimod

    go.drugbank.com/drugs/DB05513
    Investigational

    Synonyms: 2-AZASPIRO(4.5)DECANE-2-PROPANAMINE N,N-DIETHYL-8,8-DIPROPYL-, N,N-Diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propanamine
  10. Drug

    TH0318

    go.drugbank.com/drugs/DB05145
    Experimental

    TH0318 is a stabilized analogue of human GLP-1 (glucagon-like peptide-1) under investigation for the treatment of type 2 diabetes.